← FDA Warning Letters
RenatiLabs Inc.
FDA Warning Letter · 2023-08-01 · Division of Biological Products Operations I
Letter
- Company
- RenatiLabs Inc.
- Posted Date
- 2023-08-01
- Letter Issue Date
- 2023-06-01
- Issuing Office
- Division of Biological Products Operations I
Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown